ACLX
ACLX
NASDAQ · Biotechnology

Arcellx Inc

$115.07
+0.00 (+0.00%)
Analyst Consensus
Hold
14
Analysts
Moderate
Coverage
Buy 0 0%
Hold 11 79%
Sell 3 21%
Price Target
Analyst Price Target -15.7% upside
Low Target $73.10
Average Target $96.95
High Target $131.09
Current Price $115.07
Current
$115.07
Target
$96.95
$73.10 $96.95 avg $131.09
Scenario Analysis
Bear Case
$73.10
-36.5%
Low target
Base Case
$96.95
-15.7%
Avg target
Bull Case
$131.09
+13.9%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$115.13
-0.1% from high
52-Week Low
$60.36
+90.7% from low
50-Day SMA
$67.56
+70.3% vs SMA
200-Day SMA
$71.93
+60.0% vs SMA
RSI (14)
44.8
Neutral
Target vs 52W High
$96.95
-15.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +5.4%
AMGN
Amgen Inc
Hold 43 49% $190.87 -52.7%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +179.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -42.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -46.0%
BIIB
Biogen Inc
Buy 44 64% $91.45 -55.7%